Impact of perioperative intraperitoneal chemotherapy on the treatment of primary gastric cancer

Surgical Oncology Clinics of North America

Volumn 12, Issue 3, 2003, Pages 623-634

  Yu, Wansik ^a  

^a Kyungpook National University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL; MITOMYCIN; MITOMYCIN C;

ADVANCED CANCER; BONE MARROW TOXICITY; CANCER CONTROL; CANCER INVASION; CANCER SURGERY; CANCER SURVIVAL; CHEMOSURGERY; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; GASTRECTOMY; HUMAN; MALE; PROGNOSIS; REVIEW; SIDE EFFECT; STOMACH CANCER; SURVIVAL RATE;

EID: 0042243613     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1055-3207(03)00025-5     Document Type: Review

References (23)

1. Akoh JA, Macintyre IM. Improving survival in gastric cancer: review of 5 year survival rates in English language publication from 1970. Br J Surg 1992;79(4):293-9.
2. Maruyama K, Okabayashi K, Kinoshita T. Progress in gastric cancer surgery in Japan and its limits of radicality. World J Surg 1987;11(4):418-25.
3. Sendler A, Dittler HJ, Feussner H, Nekarda H, Bollschweiler E, Fink U, et al. Preoperative staging of gastric cancer as precondition for multimodal treatment. World J Surg 1995;19(4):501-8.
4. Hansen E, Wolff N, Knuechel R, Ruschoff J, Hofstaedter F, Taeger K. Tumor cells in blood shed from surgical field. Arch Surg 1995;130(4):387-93.
5. Sugarbaker PH, Cunliffe WJ, Belliveau J, de Bruijn EA, Graves T, Mullins RE, et al. Rationale for integrating early postoperative intraperitoneal chemotherapy into the surgical treatment of gastrointestinal cancer. Semin Oncol 1989;16(4 Suppl 6):83-97.
6. Hallissey MT, Dunn JA, Ward LC, Allum WH. The second British Stomach Cancer Group trial of adjuvant radiotherapy or chemotherapy in resectable gastric cancer: five-year follow-up. Lancet 1994;343(8909):1309-12.
7. Douglass HO Jr, Smith JL, Penetrante R, Nava HR. Natural history of gastric cancer: implications for adjuvant therapy trials, a study of 305 autopsies of gastric cancer patients. In: Proceedings of the 7th Seoul International Cancer Symposium. Seoul; 1994. p. 22-7.
8. Markman M. Intraperitoneal chemotherapy for malignant diseases of the gastrointestinal tract. Surg Gynecol Obstet 1987;164(1):89-93.
9. Yu W, Whang I. Complications of early postoperative intraperitoneal chemotherapy. J Korean Cancer Assoc 1991;23(4):821-7.
10. Averbach AM, Jacquet P. Strategies to decrease the incidence of intra-abdominal recurrence in resectable gastric cancer. Br J Surg 1996;83(6):726-33.
11. Gunduz N, Fisher B, Saffer EA. Effect of surgical removal on the growth and kinetics of residual tumor. Cancer Res 1979;39(10):3861-5.
12. Fisher B, Gunduz N, Saffer EA. Influence of the interval between primary tumor removal and chemotherapy in kinetics and growth of metastases. Cancer Res 1983;43(4):1488-92.
13. Jacquet P, Stuart OA, Dalton R, Chang D, Sugarbaker PH. Effect of intraperitoneal chemotherapy and fibrinolytic therapy on tumor implantation in wound sites. J Surg Oncol 1996;62(2):128-34.
14. Douglass HO Jr. Gastric cancer: overview of current therapies. Semin Oncol 1985; 12(3 Suppl 4):57-62.
15. Hagiwara A, Takahashi T, Kojima O, Sawai K, Yamaguchi T, Yamane T, et al. Prophylaxis with carbon-adsorbed mitomycin against peritoneal recurrence of gastric cancer. Lancet 1992;339(8794):629-31.
16. Rosen HR, Jatzko G, Repse S, Potrc S, Neudorfer H, Sandbichler P, et al. Adjuvant intraperitoneal chemotherapy with carbon-adsorbed mitomycin in patients with gastric cancer: results of a randomized multicenter trial of the Austrian Working Group for Surgical Oncology. J Clin Oncol 1998;16(8):2733-8.
17. Atiq OT, Kelsen DP, Shiu MH, Salz L, Tong W, Niedzwiecki D, et al. Phase II trial of postoperative adjuvant intraperitoneal cisplatin and fluorouracil and systemic fluorouracil chemotherapy in patients with resected gastric cancer. J Clin Oncol 1993;11(3):425-33.
18. Sautner T, Hofbauer F, Depisch D, Schiessel R, Jakesz R. Adjuvant intraperitoneal cisplatin chemotherapy does not improve long-term survival after surgery for advanced gastric cancer. J Clin Oncol 1994;12(5):970-4.
19. Yu W, Whang I, Suh I, Averbach A, Chang D, Sugarbaker PH. Prospective randomized trial of early postoperative intraperitoneal chemotherapy as an adjuvant to resectable gastric cancer. Ann Surg 1998;228(3):347-54.
20. Sobin LH, Wittekind Ch. The general rules of the TNM system. In: UICC TNM classification of malignant tumours. 5th ed. New York: Wiley-Liss; 1997. p. 6-8.
21. Yu W, Whang I, Averbach A, Chang D, Sugarbaker PH. Morbidity and mortality of early postoperative intraperitoneal chemotherapy as adjuvant therapy for gastric cancer. Am Surg 1998;64(11):1104-8.
22. Yonemura Y, Ninomiya I, Kaji M, Sugiyama K, Fujimura K, Sawa T, et al. Prophylaxis with intraoperative chemohyperthermia against peritoneal recurrence of serosal invasion-positive gastric cancer. World J Surg 1995;19(3):450-5.
23. Takahashi T, Hagiwara A, Shimotsuma M, Sawai K, Yamaguchi T. Prophylaxis and treatment of peritoneal carcinomatosis: intraperitoneal chemotherapy with mitomycin C bound to activated carbon particles. World J Surg 1995;19(4):565-9.